AHDC1 and fatty liver disease: Interestingly, in a recent study, Li and colleagues [29] established an Ahdc1± mouse strain that exhibited obesity, hyperleptinemia, insulin resistance, abnormal glycolipid metabolism, and hepatic steatosis, which suggest that Ahdc1 may be a key regulator of obesity and energy metabolism.